Table 1 Clinicopathologic features of the patients

From: Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer

 

Patient number (%)

Total patients

55

Sex: male/female

36/19

ECOG performance

 

 0

9 (16.4)

 1

39 (70.9)

 2

7 (12.7)

Treatments for primary tumour

 

 No prior therapy

31 (56.4)

 Surgery only

18 (32.7)

 Surgery + adjuvant chemotherapy

6 (10.9)

Disease status

 

 Locally advanced

3 (5.5)

 Recurrence/metastasis

52 (94.6%)

Disease sites

 

 Liver

26 (47.3)

 Lymph nodes

28 (50.9)

 Peritoneum

15 (27.3)

 Gastrointestinal tract

9 (16.4)

 Bone

9 (16.4)

 Lung

5 (9.1)

 Others

11 (20)